CIK 0001396814
- Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 510619477
- Phone
- +1 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $217,920
- in 1 filing, $218K under 10b5-1 plans
Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-08 | Reinhart Charles A. III Chief Financial Officer | Grant or award | +7,950 | 36,233 | ||
| 2022-06-08 | Reinhart Charles A. III Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +19,900 | 19,900 | ||
| 2022-06-08 | REINHARDT MAX President, Rest of World | Grant or award | +7,950 | 32,250 | ||
| 2022-06-08 | REINHARDT MAX President, Rest of World | Grant or award · Stock Option (Right to Buy) | +19,900 | 19,900 | ||
| 2022-06-08 | LARANJEIRA CHARLES ANTHONY Chief Technical Officer | Sale | −2,521 | $59.08 | $149K | 28,268 |
| 2022-06-08 | LARANJEIRA CHARLES ANTHONY Chief Technical Officer | Sale | −1,633 | $60.23 | $98K | 26,635 |
| 2022-06-08 | LARANJEIRA CHARLES ANTHONY Chief Technical Officer | Sale | −516 | $60.99 | $31K | 26,119 |
| 2022-06-08 | LARANJEIRA CHARLES ANTHONY Chief Technical Officer | Sale | −267 | $61.98 | $17K | 25,852 |
| 2022-06-08 | LARANJEIRA CHARLES ANTHONY Chief Technical Officer | Grant or award | +9,900 | 35,752 | ||
| 2022-06-08 | LARANJEIRA CHARLES ANTHONY Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +24,800 | 24,800 | ||
| 2022-06-08 | PACE GARY W Director | Grant or award | +1,160 | 137,690 | ||
| 2022-06-08 | PACE GARY W Director | Grant or award · Stock Option (Right to Buy) | +8,225 | 8,225 | ||
| 2022-06-08 | MOLLOY ANTHONY Chief Lgl & Compliance Officer | Grant or award | +7,950 | 19,950 | ||
| 2022-06-08 | MOLLOY ANTHONY Chief Lgl & Compliance Officer | Grant or award · Stock Option (Right to Buy) | +19,900 | 19,900 | ||
| 2022-06-08 | McLoughlin Dennis Chief Customer Officer | Grant or award | +7,950 | 39,770 | ||
| 2022-06-08 | McLoughlin Dennis Chief Customer Officer | Grant or award · Stock Option (Right to Buy) | +19,900 | 19,900 | ||
| 2022-06-08 | Kronenfeld Mark A. Director | Grant or award | +1,160 | 17,897 | ||
| 2022-06-08 | Kronenfeld Mark A. Director | Grant or award · Stock Option (Right to Buy) | +8,225 | 8,225 | ||
| 2022-06-08 | HASTINGS PAUL J Director | Grant or award | +1,160 | 7,712 | ||
| 2022-06-08 | HASTINGS PAUL J Director | Grant or award · Stock Option (Right to Buy) | +8,225 | 8,225 |
Page 14 of 23 · 450 trades